Skip to main content

Table 1 Baseline characteristics for 40 chronic fatigued and 20 non-fatigued patients with quiescent inflammatory bowel disease (IBD)

From: B-vitamins, related vitamers, and metabolites in patients with quiescent inflammatory bowel disease and chronic fatigue treated with high dose oral thiamine

 

Patients with chronic fatigue (n = 40)

Patients with no fatigue (n = 20)

p-value

Age, years; mean (SD)

37.3 (12.7)

33.0 (10.2)

0.19

Sex, male; n (%)

5 (13)

3 (15)

0.79

Body weight, kg; mean (SD)

73.3 (17.7)

73.4 (14.6)

0.98

Crohns disease; n (%)

20 (50)

10 (50)

1.00

Ulcerative colitis; n (%)

20 (50)

10 (50)

1.00

Hemoglobin, g/dl; mean (SD)

8.4 (0.7)

8.4 (0.8)

0.94

CRP, mg/l; median (IQR)

4.0 (4.0–4.0)

4.0 (4.0–4.0)

0.98

Albumin, g/l; mean (SD)

40.0 (3.3)

39.2 (2.5)

0.59

Thiamine, nmol/l; mean (SD)

4.4 (4.0)

3.7 (2.6)

0.45

IBD-F I; mean (SD)

14.8 (1.9)

5.3 (2.1)

< 0.01

  1. IBD inflammatory bowel disease, SD standard deviation, CRP C-reactive protein, IQR interquartile range, IBD-F I Inflammatory Bowel Disease-Fatigue Questionnaire section I